Medical Mammography Equipment Market Report 2026

The medical mammography equipment market size has grown strongly in recent years. It will grow from $2.21 billion in 2025 to $2.37 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to rising prevalence of breast cancer, expansion of national screening initiatives, transition from analog to digital imaging, increasing awareness of early cancer detection, growth in diagnostic imaging infrastructure.

The medical mammography equipment market size is expected to see strong growth in the next few years. It will grow to $3.07 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing adoption of 3D tomosynthesis technology, growing demand for early and accurate diagnosis, expansion of preventive healthcare programs, rising investments in women’s health services, continuous improvements in mammography imaging systems. Major trends in the forecast period include growing adoption of digital and 3D mammography systems, increasing focus on early breast cancer screening programs, rising demand for high-resolution and low-dose imaging, expansion of mobile and community-based screening units, higher emphasis on diagnostic accuracy and workflow efficiency.

The rising prevalence of breast cancer is anticipated to drive the growth of the medical mammography equipment market in the coming years. Breast cancer is a condition in which cells in the breast grow uncontrollably, forming a tumor that can often be detected through an X-ray or felt as a lump. The increase in breast cancer cases is linked to greater exposure to endocrine-disrupting chemicals, which interfere with hormonal balance and increase the risk of hormone-related tumor development. Medical mammography equipment facilitates early detection of breast cancer, enabling timely treatment and improved survival outcomes. For example, in July 2024, the Australian Institute of Health and Welfare, an Australia-based government agency, reported that approximately 20,500 cases of breast cancer were diagnosed in females in 2023. Therefore, the rising prevalence of breast cancer is fueling the growth of the medical mammography equipment market.

Leading companies in the medical mammography equipment market are concentrating on developing innovative technologies, such as digital breast tomosynthesis (DBT), to improve early detection of breast cancer, enhance diagnostic accuracy, reduce recall rates, and provide more personalized and efficient patient care. Digital breast tomosynthesis (DBT) is an advanced imaging technique that produces 3D-like images of the breast by capturing multiple X-ray images from different angles. For instance, in October 2023, Siemens Healthineers, a Germany-based medical technology company, introduced the Mammomat B. Brilliant, a next-generation tomosynthesis mammography system. This advanced device features a wide-angle tube design, enhancing 3D breast imaging for more accurate cancer detection. The system is designed to deliver high-resolution images while ensuring patient comfort and minimizing radiation exposure. This development aims to advance breast cancer diagnostics through more precise and efficient screening. The Mammomat B. Brilliant demonstrates the company’s dedication to utilizing cutting-edge imaging technologies in women’s health.

In November 2024, Radon Medical Imaging, Inc., a U.S.-based medical imaging company, acquired Alpha Imaging LLC for an undisclosed sum. Through this acquisition, Radon Medical Imaging, Inc. seeks to broaden its diagnostic imaging capabilities and strengthen service offerings by incorporating Alpha Imaging LLC’s imaging technologies and expertise to enhance diagnostic accuracy and operational efficiency. Alpha Imaging LLC is a U.S.-based medical technology company specializing in delivering advanced imaging equipment and solutions to healthcare providers.

Major companies operating in the medical mammography equipment market are Siemens Healthineers, Fujifilm Holdings Corporation, Koninklijke Philips N.V., GE Healthcare, Konica Minolta Inc., Hologic Inc., Canon Medical Systems Corporation, Carestream Health, Analogic Corporation, SuperSonic Imagine, Planmed Oy, DMS Imaging, Allengers Medical Systems Limited, Delphinus Medical Technologies Inc., CMR Naviscan, Metaltronica S.p.A., SonoCine Inc., Koning Corporation, Micrima Limited, BMI Biomedical International.

North America was the largest region in the medical mammography equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical mammography equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical mammography equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs impact the medical mammography equipment market by increasing costs of imported imaging components, digital detectors, and advanced software systems. Hospitals and diagnostic imaging centers in north america, europe, and asia-pacific are most affected due to reliance on global manufacturers. Higher tariffs may slow equipment upgrades and new installations. At the same time, they encourage local manufacturing and regional assembly, supporting long-term market resilience.

The medical mammography equipment market research report is one of a series of new reports that provides medical mammography equipment market statistics, including medical mammography equipment industry global market size, regional shares, competitors with a medical mammography equipment market share, detailed medical mammography equipment market segments, market trends and opportunities, and any further data you may need to thrive in the medical mammography equipment industry. This medical mammography equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical mammography equipment is a specialized imaging technology designed for the early detection and diagnosis of breast cancer. It employs low-dose X-rays to produce detailed images of breast tissue, aiding in the identification of abnormalities such as tumors or calcifications. The equipment generally consists of a mammography machine, image processing systems, and advanced analysis software.

The primary types of medical mammography equipment include analog mammography equipment, digital mammography equipment, 3D mammography (tomosynthesis), MRI mammography, and screening mammography systems. Analog mammography equipment captures breast images using conventional X-ray film. The technologies involved include film-based systems, digital systems, computed radiography, and computed tomography. These are applied in various areas such as breast cancer screening, diagnostic mammography, monitoring treatment progress, research and development in breast health, and are utilized by different end-users including hospitals, diagnostic imaging centers, specialized clinics, and research institutions.

The medical mammography equipment market consists of sales of diagnostic mammography, contrast-enhanced mammography, magnetic resonance imaging. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.